Results 161 to 170 of about 2,472,934 (277)

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Health and environmental impacts of shifting to plant-based analogues: a risk-benefit assessment. [PDF]

Eur J Nutr
Carvalho C, Correia D, Costa SA, Pereira R, Oliveira A, Pinto E, Lopes C, Torres D.   +7 more
europepmc   +1 more source

Risk-benefit assessment of cold-smoked salmon: microbial risk versus nutritional benefit [PDF]

, 2012
Andersen, Rikke, Berjia, Firew Lemma, Hoekstra, Jeljer, Nauta, Maarten, Poulsen, Morten   +4 more
core  

The Impact of Tilburg Frailty on Poststroke Fatigue in First‐Ever Stroke Patients: A Cross‐Sectional Study With Unified Measurement Tools and Improved Statistics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen, Xiao‐Xue Wang, Shao‐Rui Bao, Sui‐Li Lin, Mei‐Chun Shu, Xi‐Xi Ye, Wen‐Jie Cong   +6 more
wiley   +1 more source

Prediction Model for Etiologic Differentiation of Isolated Vestibular Syndrome in Emergency Settings

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to develop and validate a predictive model for differentiating central from peripheral etiologies in patients with isolated vestibular syndrome (VS). Methods In this multicenter retrospective cohort study, 506 patients with isolated VS from five hospitals were divided into derivation (n = 301) and validation (n = 205)
Guo Wenting, Du Liping, Yang Yi, Hu Jin, Ye Bijun, Wang Jianer, Liu Shuangsi, Guo Shunyuan, Cai Xiaofeng, Wang Huiyuan, Wu Bin, Yu Xiang, Shi Tianming   +12 more
wiley   +1 more source

Metal(loid)s and minerals in fish tissues: health risk-benefit assessment and variations by gender and size. [PDF]

Environ Geochem Health
Varol M, Kaçar E, Polat Y.
europepmc   +1 more source

Risk-benefit assessment of food

, 2017
Hanna Eneroth, Helga Gunnlaugsdóttir, Nils- Gunnar Ilbäck, Inger Therese Laugsand Lillegaard, Morten Poulsen, Maria Rönnqvist   +5 more
openaire   +2 more sources

Nationwide Survey of Atopic Myelitis and Plexin D1‐Immunoglobulin G‐Related Pain

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To elucidate the features of plexin D1‐immunoglobulin (Ig)G‐associated neuropathic pain and its relationship to atopic myelitis (AM) in a nationwide Japanese survey. Methods A preliminary survey questionnaire was sent to 1574 selected departments (neurology and pediatrics/pediatric neurology) to explore the numbers of AM and plexin ...
Jun‐ichi Kira, Xu Zhang, Takayuki Fujii, Mikio Mitsuishi, Miho Ushijima, Sato Yoshidomi, Ayako Sakoda, Tomohiro Imamura, Satoshi Kuwabara, Noriko Isobe, Yuri Nakamura   +10 more
wiley   +1 more source

Artificial Intelligence for Risk-Benefit Assessment in Hepatopancreatobiliary Oncologic Surgery: A Systematic Review of Current Applications and Future Directions on Behalf of TROGSS-The Robotic Global Surgical Society. [PDF]

Cancers (Basel)
Goyal A, Koutentakis M, Park J, Macias CA, Ballard I, Law SH, Babu A, Lau ECA, Mendoza M, Acosta SVJ, Abou-Mrad A, Marano L, Oviedo RJ.   +12 more
europepmc   +1 more source

The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform. [PDF]

Vaccine, 2021
Volkmann A, Williamson AL, Weidenthaler H, Meyer TPH, Robertson JS, Excler JL, Condit RC, Evans E, Smith ER, Kim D, Chen RT, Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG.   +11 more
europepmc   +1 more source